MedCity News February 13, 2025
Medicare Advantage plans can more effectively position themselves for success under an evolving measurement system. Here are three strategic actions health plan leaders should prioritize to enhance 2026 bids to secure stronger Star Rating performance.
When the 2025 Medicare Advantage Star Ratings were announced, only 42% of plans with prescription drug coverage scored four or five stars, down from 68% in 2022. This marks the third consecutive year of decline of high-performance plans — turning up the heat for Medicare Advantage (MA) plans to adjust their strategies to protect performance.
Now, as health plans prepare their 2026 bids, leaders should consider incorporating novel incentive programs in these bids—incorporating tactics proven to work in patients with health complexities — to...
Today's Sponsors
Today's Sponsor